Compare IVF HARTMANN Holding AG with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 9.93%
- The company has been able to generate a Return on Equity (avg) of 9.93% signifying low profitability per unit of shareholders funds
2
Company has a low Debt to Equity ratio (avg) at times
3
Poor long term growth as Operating profit has grown by an annual rate -0.11% of over the last 5 years
4
The company has declared Positive results for the last 4 consecutive quarters
5
With ROE of 13.08%, it has a Expensive valuation with a 2.26 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
0%
0%
0.0%
1 Year
-14.37%
0%
-14.37%
2 Years
-1.44%
0%
-1.44%
3 Years
17.09%
0%
17.09%
4 Years
16.1%
0%
16.1%
5 Years
-23.46%
0%
-23.46%
IVF HARTMANN Holding AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.34%
EBIT Growth (5y)
-0.11%
EBIT to Interest (avg)
16.80
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.71
Sales to Capital Employed (avg)
1.05
Tax Ratio
15.78%
Dividend Payout Ratio
49.47%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.75%
ROE (avg)
9.93%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.26
EV to EBIT
10.77
EV to EBITDA
8.72
EV to Capital Employed
4.36
EV to Sales
1.49
PEG Ratio
2.21
Dividend Yield
4.53%
ROCE (Latest)
40.51%
ROE (Latest)
13.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
158.80
148.00
7.30%
Operating Profit (PBDIT) excl Other Income
24.70
17.60
40.34%
Interest
0.30
0.00
Exceptional Items
-0.60
-0.10
-500.00%
Consolidate Net Profit
20.30
15.10
34.44%
Operating Profit Margin (Excl OI)
123.00%
82.10%
4.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 7.30% vs -1.73% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 34.44% vs 34.82% in Dec 2023
About IVF HARTMANN Holding AG 
IVF HARTMANN Holding AG
Pharmaceuticals & Biotechnology
IVF HARTMANN Holding AG (IVF) is a Switzerland-based holding company engaged in the field of medical supplies. The Company's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The Company also offers consulting services, on-site or in classrooms, related to the usage of its products. The Company's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. It also operates subsidiaries located in Switzerland.






